Tag: research

Our Future Leader, Dr Ángel Álvarez-Prado, is now leading his own research group at the Luxembourg Institute of Health.

At The Brain Tumour Charity, we are committed to ensuring that the voices of those directly affected by brain tumours are at the heart of everything we do. This is why, in 2024, we established a new Lay Advisory Board to help us fund the best possible research.

We are pleased to introduce two more researchers who have been awarded our latest Expanding Theories grant!

Research we’re funding in partnership with The Oli Hilsdon Foundation at University College London is using advanced brain mapping to reveal how glioblastoma spreads and resists treatment, providing insight for potential new treatments.

This year has been an exciting year for our research. Read more as we share some of 2024’s best bits.

Caring for someone with a lower-grade glioma has a profound impact on the lives of carers. The Ways Ahead Project aims to better understand this to inform the best ways to support those affected.

Involvement volunteer Baljit Ahluwalia lost her mother, Harbans Kaur Walia, to glioblastoma in 2020.

Bryony Powell knew very little about brain tumours before her fiancé, Catherine Roberts, was diagnosed with a glioblastoma in April 2018.

We’re delighted to announce that The Jake McCarthy Foundation has donated £30,000 towards Dr Tyler Miller’s research into combating gliomas with immunotherapy

We are pleased to announce the two researchers who have been awarded our latest Expanding Theories grant!

The biennial CRUK Brain Tumour Conference returned to London for 2024.

Researchers in Newcastle have found a key genetic variation in medulloblastomas that may pave the way for more effective targeted treatments.

Our Junior Fellow Dr Spencer Watson and his team at The Ludwig Institute for Cancer Research at the University of Lausanne in Switzerland are researching new ways to treat glioblastoma.

This month we sponsored an event in Manchester which brought together brain tumour experts to talk about new technologies that could improve brain tumour care.

The National Institute for Health and Care Research (NIHR) has announced two new calls for research into brain tumours.

With our funding, researchers in Canada have found key features in different meningiomas that can help predict tumour response to the most common treatments.

Ribociclib – a drug already used to treat breast cancer – may help slow the growth of diffuse hemispheric glioma.

Innovative imaging technology and machine learning developed by our Future Leader, Dr Spencer Watson, helps us understand how glioblastomas respond to treatment.

The guidelines recently published by NICE mean that NHS England will be using dabrafenib and trametinib – the first ever targeted treatment for childhood brain tumours – to treat children whose tumours have a BRAF V600E mutation.

The Ways Ahead project aims to find ways to support, and improve quality of life for those diagnosed with a lower-grade brain tumour. It also explores ways to help friends and family who are supporting those diagnosed.

We are pleased to announce the two researchers who have been awarded our latest Expanding Theories grant!

Research that we funded nearly 20 years ago laid the foundations for last week’s approval of dabrafenib and trametinib to treat childhood gliomas.

Peter Buckle is a patient advocate and has worked with several teams, including the ARISTOCRAT team to champion research and clinical trials.

Living with a lower-grade glioma has a profound impact on those diagnosed, and their families. This is well documented anecdotally but needs to be scientifically addressed so that everyone affected by a brain tumour diagnosis gets the help and support they need.